bariatric surgery vs semaglutide vs. GLP-1 Medications: What the Latest Research Shows 🥼🧪 NEW CLINICAL TRIAL: Bariatric

If approved by the FDA, orforglipron will be the first oral GLP-1 medication for weight loss

Can contain added sugars and unhealthy fats Many commercial peanut butter brands contain added sugars, hydrogenated oils (trans fats), and extra salt

These medications enhance your body's natural insulin secretion when blood glucose rises, which can lead to faster blood sugar spikes followed by sharper drops

Meanwhile, Hims and Hers, which sells compounded semaglutide, has been running weekly ads on the obesity epidemic in The New York Times, highlighting the disruption that could occur should the FDA crack down on compounded versions of GLP-1s.

By automating decision-making and streamlining processes, these clinics can offer a more efficient and effective solution for patients seeking GLP-1 treatment